BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 30616961)

  • 1. Hepatocellular Carcinoma Screening Is Associated With Increased Survival of Patients With Cirrhosis.
    Choi DT; Kum HC; Park S; Ohsfeldt RL; Shen Y; Parikh ND; Singal AG
    Clin Gastroenterol Hepatol; 2019 Apr; 17(5):976-987.e4. PubMed ID: 30616961
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HCC surveillance improves early detection, curative treatment receipt, and survival in patients with cirrhosis: A meta-analysis.
    Singal AG; Zhang E; Narasimman M; Rich NE; Waljee AK; Hoshida Y; Yang JD; Reig M; Cabibbo G; Nahon P; Parikh ND; Marrero JA
    J Hepatol; 2022 Jul; 77(1):128-139. PubMed ID: 35139400
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatocellular Carcinoma Screening in a Contemporary Cohort of At-Risk Patients.
    Daher D; Seif El Dahan K; Rich NE; Tayob N; Merrill V; Huang DQ; Yang JD; Kulkarni AV; Kanwal F; Marrero J; Parikh N; Singal AG
    JAMA Netw Open; 2024 Apr; 7(4):e248755. PubMed ID: 38683607
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatocellular Carcinoma Screening Associated with Early Tumor Detection and Improved Survival Among Patients with Cirrhosis in the US.
    Singal AG; Mittal S; Yerokun OA; Ahn C; Marrero JA; Yopp AC; Parikh ND; Scaglione SJ
    Am J Med; 2017 Sep; 130(9):1099-1106.e1. PubMed ID: 28213044
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Barriers to Surveillance for Hepatocellular Carcinoma in a Multicenter Cohort.
    Parikh ND; Tayob N; Al-Jarrah T; Kramer J; Melcher J; Smith D; Marquardt P; Liu PH; Tang R; Kanwal F; Singal AG
    JAMA Netw Open; 2022 Jul; 5(7):e2223504. PubMed ID: 35867057
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Medicaid and Uninsured Hepatocellular Carcinoma Patients Have More Advanced Tumor Stage and Are Less Likely to Receive Treatment.
    Wang J; Ha J; Lopez A; Bhuket T; Liu B; Wong RJ
    J Clin Gastroenterol; 2018; 52(5):437-443. PubMed ID: 28723861
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early detection, curative treatment, and survival rates for hepatocellular carcinoma surveillance in patients with cirrhosis: a meta-analysis.
    Singal AG; Pillai A; Tiro J
    PLoS Med; 2014 Apr; 11(4):e1001624. PubMed ID: 24691105
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Racial and Ethnic Differences in Presentation and Outcomes of Hepatocellular Carcinoma.
    Rich NE; Hester C; Odewole M; Murphy CC; Parikh ND; Marrero JA; Yopp AC; Singal AG
    Clin Gastroenterol Hepatol; 2019 Feb; 17(3):551-559.e1. PubMed ID: 29859983
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low Rates of Retention Into Hepatocellular Carcinoma (HCC) Surveillance Program After Initial HCC Screening.
    Robinson A; Tavakoli H; Cheung R; Liu B; Bhuket T; Wong RJ
    J Clin Gastroenterol; 2019 Jan; 53(1):65-70. PubMed ID: 29629906
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cirrhosis Patients with Nonalcoholic Steatohepatitis Are Significantly Less Likely to Receive Surveillance for Hepatocellular Carcinoma.
    Tavakoli H; Robinson A; Liu B; Bhuket T; Younossi Z; Saab S; Ahmed A; Wong RJ
    Dig Dis Sci; 2017 Aug; 62(8):2174-2181. PubMed ID: 28474143
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proportion of Time Covered by Hepatocellular Carcinoma Surveillance in Patients With Cirrhosis.
    Daher D; Seif El Dahan K; Yekkaluri S; Gopal P; Rich NE; Parikh ND; Murphy CC; Singal AG
    Am J Gastroenterol; 2024 May; 119(5):875-882. PubMed ID: 37975606
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inadequate Hepatocellular Carcinoma Screening in Patients With Nonalcoholic Steatohepatitis Cirrhosis.
    Aby E; Phan J; Truong E; Grotts J; Saab S
    J Clin Gastroenterol; 2019 Feb; 53(2):142-146. PubMed ID: 29912761
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of Cirrhosis on Short-term and Long-term Survival of Patients With Hepatitis B-related Hepatocellular Carcinoma.
    Chen VL; Le AK; Kim NG; Kim LH; Nguyen NH; Nguyen PP; Zhao C; Nguyen MH
    Clin Gastroenterol Hepatol; 2016 Jun; 14(6):887-895.e1. PubMed ID: 26820401
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatocellular Carcinoma Surveillance Among Patients With Cirrhosis in a Population-based Integrated Health Care Delivery System.
    Singal AG; Tiro J; Li X; Adams-Huet B; Chubak J
    J Clin Gastroenterol; 2017 Aug; 51(7):650-655. PubMed ID: 27870642
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prediagnostic CT or MRI Utilization and Outcomes in Hepatocellular Carcinoma: SEER-Medicare Database Analysis.
    Karim MA; Singal AG; Kum HC; Lee YT; Park S; Rich NE; Noureddin M; Yang JD
    Cancer Res Commun; 2023 May; 3(5):874-883. PubMed ID: 37377892
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Utilization of surveillance for hepatocellular carcinoma among hepatitis C virus-infected veterans in the United States.
    Davila JA; Henderson L; Kramer JR; Kanwal F; Richardson PA; Duan Z; El-Serag HB
    Ann Intern Med; 2011 Jan; 154(2):85-93. PubMed ID: 21242365
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improved Survival in Patients with Viral Hepatitis-Induced Hepatocellular Carcinoma Undergoing Recommended Abdominal Ultrasound Surveillance in Ontario: A Population-Based Retrospective Cohort Study.
    Thein HH; Campitelli MA; Yeung LT; Zaheen A; Yoshida EM; Earle CC
    PLoS One; 2015; 10(9):e0138907. PubMed ID: 26398404
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improved Survival of Hepatocellular Carcinoma Patients Diagnosed with a Dedicated Screening Programme-a Propensity Score Adjusted Analysis.
    Chinnaratha MA; Campbell K; Mathias R; McCormick RJ; Woodman RJ; Wigg AJ
    J Gastrointest Cancer; 2019 Dec; 50(4):888-893. PubMed ID: 30345486
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of socioeconomics, surgical therapy, and survival of early stage hepatocellular carcinoma.
    Peters NA; Javed AA; He J; Wolfgang CL; Weiss MJ
    J Surg Res; 2017 Apr; 210():253-260. PubMed ID: 28457336
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Factors associated with unrecognized cirrhosis in patients with hepatocellular carcinoma.
    Lee YT; Karim MA; Kum HC; Park S; Rich NE; Noureddin M; Singal AG; Yang JD
    Clin Mol Hepatol; 2023 Apr; 29(2):453-464. PubMed ID: 36726052
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.